9.12
전일 마감가:
$8.86
열려 있는:
$8.95
하루 거래량:
924.06K
Relative Volume:
1.20
시가총액:
$540.09M
수익:
$1.08B
순이익/손실:
$139.50M
주가수익비율:
3.8457
EPS:
2.3715
순현금흐름:
$205.80M
1주 성능:
+3.52%
1개월 성능:
-13.39%
6개월 성능:
-36.40%
1년 성능:
-33.09%
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
9.12 | 524.69M | 1.08B | 139.50M | 205.80M | 2.3715 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M - Drug Delivery Business
Embecta to buy Owen Mumford for up to $201M - MedTech Dive
Embecta rallies after UK firm deal worth $200 million - MSN
Embecta to acquire UK medical device maker Owen Mumford for $200M - NJBIZ
Embecta (NASDAQ:EMBC) Trading 4.5% HigherTime to Buy? - MarketBeat
Embecta to Acquire Owen Mumford for up to $199.4M - Medical Product Outsourcing
Embecta’s $133M Acquisition of Owen Mumford Marks a Turning Point - Medical Device and Diagnostic industry
Embecta Rallies After UK Firm Deal Worth $200 Million - Benzinga
Embecta to buy Owen Mumford for up to £150M - MSN
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal - Investing.com
Embecta announces definitive agreement to acquire Owen Mumford Holdings Limited - marketscreener.com
Embecta to acquire Owen Mumford for up to £150 million - Investing.com
Embecta’s Purchase of Owen Mumford Establishes Q3 2026 as a Key Driver for Surpassing Earnings Expectations and Strategic Valuation Shift - Bitget
Embecta bets up to £150M to expand from diabetes care into drug delivery - Stock Titan
Embecta (NASDAQ:EMBC) Reaches New 1-Year LowShould You Sell? - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - MarketBeat
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
The Technical Signals Behind (EMBC) That Institutions Follow - Stock Traders Daily
Embecta Corp. Stock Plummets to New 52-Week Low of $9.06 - Markets Mojo
Embecta Corp. Stock Plummets to New 52-Week Low of $8.81 - Markets Mojo
Embecta (NASDAQ:EMBC) Hits New 1-Year LowHere's What Happened - MarketBeat
NanoTess lands Embecta deal to put its tech in 14,000 Canadian pharmacies - BetaKit
Embecta Stock Pre-Market (+6.5%): Enters Wound Care Market with Canadian Distribution Deal - Trefis
Calgary Startup NanoTess Signs Deal with Diabetes Care Leader embecta to Bring Catalytic Wound Care to All Canadians - Yahoo Finance
Jefferies Financial Group Inc. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta (NASDAQ:EMBC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Technical Analysis: Can Embecta Corp withstand a market correctionJuly 2025 Institutional & Weekly Top Gainers Trade List - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Sets New 52-Week LowHere's What Happened - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
William Blair Investment Management LLC Sells 312,857 Shares of Embecta Corp. $EMBC - MarketBeat
Precision Trading with Embecta Corp. (EMBC) Risk Zones - Stock Traders Daily
InvestingPro’s Fair Value spotted Embecta overvaluation before 47% drop By Investing.com - Investing.com South Africa
EMBCEmbecta Corp Latest Stock News & Market Updates - Stock Titan
Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors - DirectorsTalk Interviews
EMBC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Drivers: Why is Embecta Corp stock going upWeekly Volume Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn
BTIG Keeps Their Buy Rating on Embecta Corporation (EMBC) - The Globe and Mail
Embecta Corp. (EMBC) Stock Analysis: A 58.28% Potential Upside In Medical Device Innovation - DirectorsTalk Interviews
Public Sector Pension Investment Board Increases Stock Position in Embecta Corp. $EMBC - MarketBeat
Technical Reactions to EMBC Trends in Macro Strategies - Stock Traders Daily
Does Embecta Corp. have high return on assets2025 Volatility Report & Safe Swing Trade Setup Alerts - mfd.ru
Embecta shareholders back board, pay, and equity plan - The Globe and Mail
Will Embecta Corp. stock gain from lower inflationPortfolio Performance Report & High Conviction Buy Zone Alerts - mfd.ru
Why analysts remain bullish on Embecta Corp. stockPortfolio Return Summary & Reliable Price Breakout Signals - mfd.ru
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively - simplywall.st
Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem - 富途牛牛
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta names new Chairman of the Board and Lead Independent Director - The Manila Times
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):